SOLICITATION NOTICE
B -- Manufacture of Bulk Chemicals and Bulk Pharmaceutical Ingredients for Preclinical and Clinical Studies - See attached RFP and attachments.
- Notice Date
- 3/3/2017
- Notice Type
- Combined Synopsis/Solicitation
- NAICS
- 325412
— Pharmaceutical Preparation Manufacturing
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Office of Acquisitions, 9609 Medical Center Drive, Room 1E128, Rockville, Maryland, 20852, United States
- ZIP Code
- 20852
- Solicitation Number
- N02CM77007-98
- Archive Date
- 4/18/2017
- Point of Contact
- Stephen C. Shaffer, Phone: (301) 624-8759, C. Timothy Crilley, Phone: (301) 624-8743
- E-Mail Address
-
Stephen.Shaffer@nih.gov, tcrilley@mail.nih.gov
(Stephen.Shaffer@nih.gov, tcrilley@mail.nih.gov)
- Small Business Set-Aside
- Total Small Business
- Description
- See attached RFP and attachments. The Developmental Therapeutics Program (DTP) at the National Cancer Institute (NCI) supports the NCI's Experimental Therapeutics (NExT) program to facilitate the transition of novel drug discoveries into clinical trials of new cancer therapeutic agents. One of essential parts of the program involves the manufacture and supply of bulk chemicals/drugs that are prepared under the current Good Manufacturing Practice (c-GMP). The bulk drugs will be used to support pre-clinical studies and to prepare clinical products that are necessary to support human clinical trials under the NCI sponsorship or investigator initiated INDs.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/RCB/N02CM77007-98/listing.html)
- Record
- SN04422763-W 20170305/170303235120-9f562db8836e30cc2dc7f586ea2c3c80 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |